Live Breaking News & Updates on Director Barbara Klencke

Stay updated with breaking news from Director barbara klencke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TScan Therapeutics' (TCRX) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a report issued on Thursday morning, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. HC Wainwright also issued estimates for TScan Therapeutics’ FY2028 earnings at ($0.21) EPS. Several other research analysts have also recently […] ....

Barbara Klencke , Timothyj Barberich , Securities Exchange Commission , Vanguard Group Inc , Tscan Therapeutics Inc , Monashee Investment Management , Blackrock Inc , Free Report , Therapeutics Trading Down , Get Free Report , Director Barbara Klencke , Exchange Commission , Director Timothy , Investment Management , Therapeutics Daily ,

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Timothyj Barberich , Barbara Klencke , Millennium Management , Exchange Commission , Tscan Therapeutics Company Profile , Renaissance Technologies , Securities Exchange Commission , Tscan Therapeutics Inc , Pale Fire Capital , Free Report , Street Group , State Street Corp , Street Corp , Director Timothy , Director Barbara Klencke , Therapeutics Stock , Therapeutics Company , Therapeutics Daily ,